This research project analyzes the capital structures and profitability of pharmaceuticals companies listed under Australian stock exchange. The study is presented for the partial fulfillment of Degree in Master of Professional Accounting in Holmesglen Institute. The research will be based on the following companies Auscann Group Holdings Ltd, Avita Medical Ltd, Benitec Biopharma Limited, Biotron Limited and Bioxyne Limited. The study will discuss whether healthcare sectors recognize capital structure as a strategic opportunity to enhance the value of the organization or to view capital structure as a by-product of another decision making.